Evidence map›Paper›PMID 34713769›Full record

ArticleBioengineered2022

Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis.

Shan Wang, Xuwen Zha, Shengting Ruan, Shoulin Yao, Xiaoyu Zhang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. KLF transcription factors in bone diseases.Journal of cellular and molecular medicine · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shan WangRheumatology and Immunology Department, the First People's Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University. Anhui, China.
Xuwen ZhaRheumatology and Immunology Department, the First People's Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University. Anhui, China.
Shengting RuanRheumatology and Immunology Department, the First People's Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University. Anhui, China.
Shoulin YaoRheumatology and Immunology Department, the First People's Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University. Anhui, China.
Xiaoyu ZhangRheumatology and Immunology Department, the First People's Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University. Anhui, China.
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease caused by synovitis. Two genes, KLF10 (Kruppel like factor 10) and PDZ and LIM domain containing protein 2 (PDLIM2), play key roles in cell inflammation and proliferation. However, the specific roles of the two on inflammation and proliferation of RA-fibroblastoid synovial cell (RA-FLS) have not been reported so far. RT-qPCR and Western blot detected the expressions of PDLIM2 and KLF10 in Human Rheumatoid arthritis FLSs (HFLSs-RA). Cell transfection techniques overexpressed PDLIM2 and KLF10 or inhibited the expression of KLF10. JAPAR database predicted the binding sites of PDLIM2 and KLF10, and the binding between the two was detected and verified using luciferase reporter genes and ChIP. Subsequently, CCK-8 technology, TUNEL staining, Western blot, wound healing and ELISA detected proliferation-related indicators, migration-related indications and inflammation-related indicators. Finally, western blot was used to detect the expression of NF-κB pathway-related proteins to further explore the mechanism.The expression of PDLIM2 was decreased in HFLSs-RA. Overexpression of PDLIM2 inhibited proliferation, migration and inflammation in HFLSs-RA. KLF10 can transcriptionally activate PDLIM2. Interfering with KLF10 reversed the inhibition effects of PDLIM2 overexpression on the proliferation, migration and inflammation, which was possibly through the NF-κB pathway. Overall, KLF10 can up-regulate PDLIM2 by regulating the NF-κB pathway to inhibit inflammation and proliferation of HFLSs-RA.

Indexed as

Arthritis, RheumatoidCell ProliferationCells, CulturedCell SurvivalEarly Growth Response Transcription FactorsHumansKruppel-Like Transcription FactorsLIM Domain ProteinsMicrofilament ProteinsNF-kappa BSignal TransductionTranscriptional ActivationUp-RegulationEarly Growth Response Transcription FactorsKLF10 protein, humanKruppel-Like Transcription FactorsLIM Domain ProteinsMicrofilament ProteinsNF-kappa BPDLIM2 protein, humanfibroblastoid synovial cellinflammatoryKLF10NF-κB pathwayPDLIM2proliferationrheumatoid arthritis

Identifiers

PMID34713769
PMCPMC8805881
OpenAlexW3208960742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.